Ilumya

Description

A drug called Ilumya provides an innovative approach to treating psoriasis.

The immunosuppressant is designed specifically for patients with moderate to severe psoriatic disease who have difficulty responding to traditional treatments.

Active ingredient: tildrakizumab

Prescription medicine